1. Home
  2. BLFS vs ABCL Comparison

BLFS vs ABCL Comparison

Compare BLFS & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLFS
  • ABCL
  • Stock Information
  • Founded
  • BLFS 1987
  • ABCL 2012
  • Country
  • BLFS United States
  • ABCL Canada
  • Employees
  • BLFS N/A
  • ABCL N/A
  • Industry
  • BLFS Medical/Dental Instruments
  • ABCL Biotechnology: Pharmaceutical Preparations
  • Sector
  • BLFS Health Care
  • ABCL Health Care
  • Exchange
  • BLFS Nasdaq
  • ABCL Nasdaq
  • Market Cap
  • BLFS 995.2M
  • ABCL 1.1B
  • IPO Year
  • BLFS 1989
  • ABCL 2020
  • Fundamental
  • Price
  • BLFS $24.34
  • ABCL $4.59
  • Analyst Decision
  • BLFS Strong Buy
  • ABCL Strong Buy
  • Analyst Count
  • BLFS 7
  • ABCL 5
  • Target Price
  • BLFS $30.86
  • ABCL $8.00
  • AVG Volume (30 Days)
  • BLFS 584.6K
  • ABCL 6.4M
  • Earning Date
  • BLFS 08-07-2025
  • ABCL 08-07-2025
  • Dividend Yield
  • BLFS N/A
  • ABCL N/A
  • EPS Growth
  • BLFS N/A
  • ABCL N/A
  • EPS
  • BLFS N/A
  • ABCL N/A
  • Revenue
  • BLFS $93,468,000.00
  • ABCL $32,875,999.00
  • Revenue This Year
  • BLFS $21.22
  • ABCL N/A
  • Revenue Next Year
  • BLFS $17.50
  • ABCL $71.11
  • P/E Ratio
  • BLFS N/A
  • ABCL N/A
  • Revenue Growth
  • BLFS 68.16
  • ABCL N/A
  • 52 Week Low
  • BLFS $19.10
  • ABCL $1.89
  • 52 Week High
  • BLFS $29.55
  • ABCL $5.82
  • Technical
  • Relative Strength Index (RSI)
  • BLFS 60.60
  • ABCL 56.32
  • Support Level
  • BLFS $22.22
  • ABCL $3.93
  • Resistance Level
  • BLFS $25.74
  • ABCL $4.77
  • Average True Range (ATR)
  • BLFS 1.22
  • ABCL 0.34
  • MACD
  • BLFS 0.44
  • ABCL -0.04
  • Stochastic Oscillator
  • BLFS 75.00
  • ABCL 61.11

About BLFS BioLife Solutions Inc.

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: